KMT2A and cancer: This is akin to its role in mixed-lineage leukemia, wherein IGF2BP3 expression, induced by the MLL-AF4 leukemogenic pathway, positively regulates MLL-AF4 transcriptional targets, creating a feedforward process that drives cancer progression [16].